Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$98.35M
↑ 179% above average
Average (9y)
$-124.19M
Historical baseline
Range
High:$98.35M
Low:$-601.08M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | $98.35M | +116.4% |
| 2024 | $-601.08M | -193.2% |
| 2023 | $-205.00M | -14.8% |
| 2022 | $-178.51M | -19.8% |
| 2021 | $-149.04M | -60.0% |
| 2020 | $-93.16M | -252.2% |
| 2019 | $61.19M | +209.4% |
| 2018 | $-55.94M | -51.2% |
| 2017 | $-37.00M | +54.7% |
| 2016 | $-81.74M | - |